Broadened Use of Magnetic Sphincter Augmentation in Weakly Acidic Reflux Patients
Overview
This study evaluates long-term outcomes of magnetic sphincter augmentation (MSA) in patients with weakly acidic reflux compared to those with standard acidic GERD. Results indicate that MSA is a safe and effective surgical option for controlling symptoms in both patient groups, with favorable postoperative quality of life and low complication rates.
Background
Gastroesophageal reflux disease (GERD) is a prevalent upper gastrointestinal disorder characterized by reflux of gastric contents causing symptoms and potential complications such as Barrett’s esophagus and esophageal adenocarcinoma. GERD can be classified by esophageal pH monitoring into acidic (pH < 4) and weakly acidic or non-acidic reflux (pH ≥ 4), both contributing to symptom burden. While proton pump inhibitors (PPIs) effectively reduce acid reflux symptoms in many patients, they do not address the dysfunctional lower esophageal sphincter or non-acidic reflux. Magnetic sphincter augmentation (MSA) offers a less invasive surgical alternative to laparoscopic fundoplication, aiming to restore LES barrier function with fewer side effects.
Data Highlights
Parameter
Weakly Acidic Reflux Group
Acidic Reflux Group
Median Follow-up (months)
24 (IQR 10–41)
24 (IQR 10–41)
Hiatoplasty Performed
81%
81%
Postoperative GERD-HRQL Score
Significant improvement reported
Significant improvement reported
Postoperative PPI Use
Marked reduction
Marked reduction
Postoperative Dysphagia
Low incidence
Low incidence
Key Findings
MSA effectively reduces GERD symptoms in patients with weakly acidic reflux similarly to those with standard acidic reflux.
Postoperative quality of life, measured by GERD-HRQL scores, improved significantly in both groups.
Hiatoplasty was performed in the majority (81%) of patients, contributing to surgical success.
MSA demonstrated a low rate of postoperative complications such as dysphagia and gas bloating.
Patients were able to discontinue or markedly reduce PPI therapy following MSA.
The surgical procedure was standardized and performed laparoscopically by an experienced team, ensuring consistency.
Clinical Implications
MSA represents a viable surgical option for patients with both acidic and weakly acidic GERD, especially those refractory to medical therapy. Its less invasive nature and favorable side effect profile compared to traditional fundoplication make it an attractive alternative. Clinicians should consider MSA in patients with documented reflux episodes and typical symptoms, including those with weakly acidic reflux who often have limited treatment options.
Conclusion
Magnetic sphincter augmentation provides effective long-term symptom control and quality of life improvement in patients with weakly acidic reflux comparable to those with acidic GERD. This broadens the surgical treatment indications and supports MSA as a safe, less invasive alternative to fundoplication.
References
Torax Medical -- LINX® Reflux Management System
Clinical studies on MSA safety and efficacy (2017-2024)
